Agios presents encouraging results of leukemia drug trial

04/6/2014 | Forbes · Reuters

In the first clinical trial of Agios' AG-221 for acute myeloid leukemia with a specific mutation, three out of the seven patients who completed the study experienced complete remission while the conditions of another three improved. The drug could help reduce the need for bone marrow transplants, said Dr. Eytan Stein, who presented the results at the 2014 American Association for Cancer Research meeting.

View Full Article in:

Forbes · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT